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We report the development of epitope-blocking enzyme-linked immunosorbent assays (ELISAs) for the rapid
detection of serum antibodies to West Nile virus (WNV) in taxonomically diverse North American avian
species. A panel of flavivirus-specific monoclonal antibodies (MAbs) was tested in blocking assays with serum
samples from WNV-infected chickens and crows. Selected MAbs were further tested against serum samples
from birds that represented 16 species and 10 families. Serum samples were collected from birds infected with
WNV or Saint Louis encephalitis virus (SLEV) and from noninfected control birds. Serum samples from
SLEV-infected birds were included in these experiments because WNV and SLEV are closely related antigeni-
cally, are maintained in similar transmission cycles, and have overlapping geographic distributions. The
ELISA that utilized MAb 3.1112G potentially discriminated between WNV and SLEV infections, as all serum
samples from WNV-infected birds and none from SLEV-infected birds were positive in this assay. Assays with
MAbs 2B2 and 6B6C-1 readily detected serum antibodies in all birds infected with WNV and SLEV, respec-
tively, and in most birds infected with the other virus. Two other MAbs partially discriminated between
infections with these two viruses. Serum samples from most WNV-infected birds but no SLEV-infected birds
were positive with MAb 3.67G, while almost all serum samples from SLEV-infected birds but few from
WNV-infected birds were positive with MAb 6B5A-5. The blocking assays reported here provide a rapid,
reliable, and inexpensive diagnostic and surveillance technique to monitor WNV activity in multiple avian
species.
West Nile virus (WNV) is a single-stranded, positive-sense
RNA virus that has been placed in the genus Flavivirus, family
Flaviviridae (2). It is a member of the Japanese encephalitis
virus complex, which also includes Saint Louis encephalitis
virus (SLEV), Murray Valley encephalitis virus, and Koutango
virus (14). These viruses are maintained in cycles between
mosquitoes and birds. The principal vectors for WNV are
Culex species mosquitoes (13). Many different wild bird species
act as reservoir hosts for WNV, whereas humans, horses, and
other mammals are usually incidental hosts. Clinical manifes-
tations associated with WNV infections in humans include
fever, headache, rash, fatigue, myalgia, and arthralgia and,
occasionally, acute hepatitis, encephalitis, and meningitis (13).
WNV was first isolated in 1937 from the blood of a febrile
adult woman in the West Nile district of Uganda (25). This
virus has since been reported in Africa, the Middle East, Asia,
southern Europe, Australia (subtype Kunjin virus), and more
recently North America (8, 13, 16, 18, 21). The initial outbreak
of WNV in North America took place in New York City in
1999, with 62 confirmed human cases and seven deaths re-
ported (8, 20). This outbreak coincided with extensive mortal-
ity in birds, particularly crows, in the same geographic area (6).
WNV rapidly spread to neighboring states, with 21 human
cases (two deaths) reported in New York, New Jersey, and
Connecticut in 2000 (18) and a further 66 human cases (nine
deaths) reported in 10 states in 2001 (21). WNV activity has
now been detected in most states in the eastern half of the
United States.
Diagnosis of WNV infections in birds is complicated by the
presence of other flaviviruses in the same geographic area. Of
particular relevance to North American surveillance programs
is SLEV, as this virus has a close antigenic and genetic rela-
tionship to WNV, is maintained in nature in similar transmis-
sion cycles, and has been isolated from wild birds (2, 7, 27).
Furthermore, SLEV is endemic throughout the United States,
particularly in the central and eastern states and in the south-
west. This virus has also been responsible for two major out-
breaks in Central America and a number of sporadic cases in
Central and South America. Other avian flaviviruses found in
the Americas include Ilheus virus (ILHV) and Bussuquara
virus (BSQV) (2).
Serologic diagnosis of WNV in birds can be achieved by
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plaque reduction neutralization tests (PRNTs). However,
PRNTs for type-specific diagnosis are laborious, and expensive
and require live virus and for these reasons are not ideal for
large-scale routine testing. Hemagglutination inhibition assays
are also labor-intensive, as bird serum samples must first un-
dergo multiple treatments for nonspecific inhibitors with ace-
tone extraction and perhaps protamine sulfate treatment (1,
15). Furthermore, hemagglutination inhibition assays are not
specific in that, with antigen for WNV, antibodies that cross-
react with other closely related flaviviruses may also be de-
tected. In contrast, direct enzyme-linked immunosorbent as-
says (ELISAs) provide a rapid, sensitive, and inexpensive
screening test for the detection of antibodies to WNV in birds
(3). However, this technique is not suitable when screening
samples from a wide variety of bird species, as different sec-
ondary (reporter) antibodies are required depending on the
species being tested.
An indirect immunoglobulin G (IgG) ELISA was recently
reported that detected WNV antibodies in all 23 avian species
and 12 orders tested (5). This assay also recognized antibodies
in SLEV-infected chickens. Antibodies were detected with a
pooled suspension of horseradish peroxidase-labeled IgG an-
tibodies from birds representing four orders. Another alterna-
tive is an epitope-blocking ELISA, which does not require the
use of multiple reporter or capture antibodies and has previ-
ously been shown to be an effective method to specifically
identify Kunjin virus infections in sentinel chickens (9). The
development of epitope-blocking ELISAs to detect antibodies
to WNV in diverse bird species would be a significant advance
not only in WNV surveillance studies, but in all flavivirus
surveillance studies.
MATERIALS AND METHODS
Cell culture. C6/36 and ATC-15 cell lines (both derived from Aedes albopictus
larvae) were cultured at 28°C with 5% CO2 in minimum essential medium
(Gibco, Grand Island, N.Y.) containing 10% heat-inactivated fetal bovine serum
(Gemini Bio-Products, Woodland, Calif.), 0.1 mM nonessential amino acids,
0.15% sodium bicarbonate, 2 mM L-glutamine, penicillin (100 U/ml), and strep-
tomycin (100 g/ml). African green monkey kidney (Vero) cells were cultured at
37°C with 5% CO2 in the same medium.
Viruses. All virus strains were obtained from the World Health Organization
Reference Center maintained at the Division of Vector-Borne Infectious Dis-
eases, Centers for Disease Control and Prevention, Fort Collins, Colo. The
viruses used in this study were WNV NY99-35261-11, SLEV TBH-28, ILHV
(original), and BSQV BeAn-4073. Virus stocks were prepared in Vero and/or
C6/36 cells, and virus titers determined by endpoint assay in Vero cells.
Bird serum samples. Birds were experimentally inoculated with WNV (NY99)
via infected Culex tritaeniorhynchus mosquitoes except for fish crows, which were
subcutaneously inoculated with 3,500 PFU of virus. All birds were sampled at 14
days postinfection, and domestic chickens were also sampled at 19, 28, and 31
days postinfection. fish crows were vaccinated with recombinant WNV prior to
infection unless otherwise stated; all other birds were not vaccinated. Serum
samples were also obtained from SLEV-infected birds captured during the 2001
St. Louis encephalitis epidemic in Monroe, La. Normal chicken serum was
purchased from Vector Laboratories, Burlingame, Calif.
Serum samples were obtained from the following birds (with species and
family names denoted in parentheses): American crows (Corvus brachyrhynchos,
Corvidae), American robins (Turdus migratorius, Turdidae), a blue jay (Cyanoc-
itta cristata, Corvidae), Canada geese (Branta canadensis, Anatidae), domestic
chickens (Gallus gallus, Phasianidae), a domestic turkey (Meleagris gallopavo,
Phasianidae), European starlings (Sturnus vulgaris, Sturnidae), fish crows (Corvus
ossifragus, Corvidae), graylag geese (Anser anser, Anatidae), a house finch (Car-
podacus mexicanus, Fringillidae), house sparrows (Passer domesticus, Passeri-
dae), Japanese quails (Coturnix japonica, Phasianidae), killdeers (Charadrius
vociferus, Charadriidae), monk parakeets (Myiopsitta monachus, Psittacidae),
mourning doves (Zenaida macroura, Columbidae), a northern bobwhite (Colinus
virginianus, Phasianidae), ring-necked pheasants (Phasianus colchicus, Phasiani-
dae), and rock doves (Columba livia, Columbidae).
Mouse hyperimmune ascitic fluids. Mouse hyperimmune ascitic fluids con-
taining antibodies against various flaviviruses (WNV, SLEV, ILHV, and BSQV)
were obtained from the World Health Organization Reference Center main-
tained at the Division of Vector-Borne Infectious Diseases, Centers for Disease
Control and Prevention, Fort Collins, Colo.
MAbs. The seven MAbs used in this study are described in Table 1. Briefly, our
panel of antibodies consisted of four WNV MAbs (3.1112G, 3.67G, 3.91D, and
2B2), two SLEV MAbs (6B6C-1 and 6B5A-2), and one Murray Valley enceph-
alitis virus MAb (3H6). All MAbs detect E protein epitopes except MAb
3.1112G, which detects an NS1 epitope. MAb 6B6C-1 was labeled with horse-
radish peroxidase; all other MAbs were unlabeled. The production and charac-
terization of these MAbs have been described elsewhere (10, 11, 23, 24).
Preparation of ELISA coating antigen. ATC-15 cell monolayers (grown in
150-cm2 culture flasks) were inoculated with the specified flavivirus at a multi-
plicity of infection of 0.01. WNV- and ILHV-infected cells were scraped from
flasks at 5 days postinfection, and SLEV- and BSQV-infected cells were scraped
from flasks at 7 days postinfection and then clarified by centrifugation at 7,000
g for 10 min at 4°C (Hermle Labnet centrifuge, model Z383K). Cell pellets were
resuspended in 6 ml of ice-cold borate saline buffer (120 mM sodium chloride, 50
mM boric acid, 24 mM sodium hydroxide, pH 9.0), clarified by centrifugation at
7,000  g for 20 min at 4°C, and washed three more times. Cell pellets were
resuspended in 900 l of 0.1% sodium dodecyl sulfate, then 100 l of Triton
X-100 and 2 ml of borate saline buffer were added to the suspension. Samples
were sonicated on ice (20% output for 30 s) and clarified by centrifugation at
TABLE 1. Flavivirus MAbs used in blocking ELISAs
MAb Virus (isolate) to which MAb was raiseda Isotype Reactivityb
2B2 WNV (subtype KUNV) (isolate MRM16) IgG2a Reacts with WNV, KOUV (A, B), no reaction with
SLEV, MVEV (C)
3.1112G WNV (subtype KUNV) (isolate OR393) IgM Reacts with WNV (B), No reaction with KOUV (D)
3.67G WNV (subtype KUNV) (isolate OR393) IgG1 Reacts with WNV, KOUV (B)
3.91D WNV (subtype KUNV) (isolate OR393) IgG3 Reacts with WNV, KOUV (B)
6B5A-2 SLEV (isolate MSI-7) IgG2a Reacts with SLEV (B); no reaction with WNV,
MVEV, JEV, YFV, DENV 1–4 (D)
6B6C-1 SLEV (isolate MSI-7) IgG2a Reacts with SLEV, WNV, MVEV, JEV, YFV,
DENV 1–4 (D)
3H6 MVEV (isolate MVE3/51) IgG2a Reacts with MVEV, SLEV, WNV, JEV, YFV,
KOKV, DENV 1–3 (E)
a Abbreviations: West Nile virus (WNV), Kunjin virus (KUNV), Koutango virus (KOUV), Saint Louis encephalitis virus (SLEV), Murray Valley encephalitis virus
(MVEV), Japanese encephalitis virus (JEV), yellow fever virus (YFV), Dengue virus (DENV), Kokobera virus (KOKV).
b Letters in parentheses indicate how reactivity was determined. A, determined by hemagglutination assay and neutralization test (10); B, determined by direct ELISA
(24); C, determined by indirect immunofluorescence antibody assay (17); D, determined by indirect immunofluorescence antibody assay (23); E, determined by
hemagglutination assay and neutralization test (11). Details of virus strains are described in the references cited above.
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15,000  g for 10 min at 4°C, and supernatants were collected and stored at
70°C. Control antigen was also prepared from uninfected cell monolayers.
Blocking ELISAs. Blocking ELISAs were performed following the protocol of
Hall et al. (9), with several modifications. Briefly, the inner 60 wells of 96-well
microtiter plates (Dynatech Industries Inc.) were coated with 100 l of antigen
diluted in carbonate-bicarbonate buffer (50 mM sodium carbonate, 50 mM
sodium bicarbonate, pH 9.6). Control antigen prepared from uninfected cell
monolayers was also used. Coated plates were incubated overnight at 4°C. Plates
were washed six times with 250 l of wash buffer (phosphate-buffered saline [pH
7.5] containing 0.1% Tween 20) with an automatic plate washer. Two hundred
microliters of blocking buffer (phosphate-buffered saline containing 5% skim
milk) was added to each well and incubated for 40 min at 37°C. After six washes,
50 l of serum diluted 1:10 was added to each well and incubated for 2 h at 37°C,
and the wells were washed again six times.
MAbs were diluted in blocking buffer at the specified dilution, added to each
well (50 l), and incubated for 1 h at 37°C. For non-horseradish peroxidase-
labeled MAbs, plates were washed, and 50 l of horseradish peroxidase-conju-
gated rabbit anti-mouse IgG (Zymed Laboratories, San Francisco, Calif.) was
added at a dilution of 1:2,000 to each well and again incubated for 1 h at 37°C,
followed by six more washes. Equal volumes of ABTS (2,2 azino-bis[3-ethyl-
benzthiazoline-6-sulfonic acid]) and peroxidase solutions from the ABTS Micro-
well peroxidase substrate system (KPL, Gaithersburg, Md.) were mixed, and 75
l was added to each well. The optical density at a wavelength of 415 nm was
determined with an automated plate reader. The percent inhibition of MAb
binding was calculated (9) as 100  [(TS  B)/(CS  B)]  100, where TS is the
mean optical density of the test serum, CS is the mean optical density of the
control serum (from uninfected chickens), and B is the background optical
density.
Test samples were typically analyzed in duplicate or triplicate, whereas at least
three wells of control chicken serum were included on each 96-well plate. The
percent inhibition was calculated once the mean optical density in the wells
containing the control serum samples exceeded 0.3. An inhibition value of30%
was considered to indicate the presence of viral antibodies (as explained later).
Plaque reduction neutralization test. The ability of serum samples from birds
to neutralize WNV and SLEV was determined by PRNT. Serum samples were
heat inactivated at 56°C for 30 min and then serially diluted twofold in BA-1
diluent (Hanks M-199 salts, 50 mM Tris [pH 7.6], 1% bovine serum albumin,
0.35 g of sodium bicarbonate per liter, 100 U of penicillin per ml, 100 mg of
streptomycin per ml, 1 mg of fungizone per ml), starting at a dilution of 1:5. Next,
100 l of diluted serum was mixed with an equal volume of diluent containing
200 PFU of virus. One hundred microliters of serum-virus suspension was trans-
ferred onto confluent Vero cell monolayers in six-well plates and incubated at
37°C for 60 min. Three milliliters of neutral red-deficient Earl’s balanced salt
solution containing 20 g of yeast extract per liter, 100 g of lactalbumin hydroly-
sate per liter, 25% fetal bovine serum, 1% fungizone-gentamicin, and 0.5%
agarose were added to each well, and the plates were incubated at 37°C for 48 h.
Then 3 ml of the same medium containing 0.22% neutral red was added to each
well at 2 or 6 days postinfection for the WNV and SLEV PRNTs, respectively.
Plaques were counted 24 h later, and titers were expressed as the reciprocal of
the serum dilution yielding90% reduction in the number of plaques (PRNT90).
All serum samples were tested in duplicate.
RESULTS
Determination of MAb flavivirus specificity. The cross-reac-
tivities of the seven MAbs against WNV, SLEV, ILHV, and
BSQV were determined by direct ELISA. The panel of MAbs
consisted of four that were raised against WNV (MAbs 2B2,
3.1112G, 3.67G, and 3.91D), two raised against SLEV (MAbs
6B5A-2 and 6B6C-1), and one raised against Murray Valley
encephalitis virus (MAb 3H6). The specificities of these MAbs
against selected flaviviruses were characterized previously (Ta-
ble 1). Four antibodies (MAbs 2B2, 3.1112G, 3.67G, and
3.91D) reacted with WNV antigen but not with SLEV, ILHV,
or BSQV antigens (data not shown). MAb 6B5A-2 specifically
reacted with SLEV antigen, whereas MAbs 6B6C-1 and 3H6
reacted with the four flaviviruses tested. For those MAbs that
failed to recognize a particular antigen, ELISAs were repeated
with multiple MAb and antigen dilutions to ensure that anti-
body binding did not occur. As expected, antibodies to WNV,
SLEV, ILHV, and BSQV in mouse hyperimmune ascitic fluids
reacted with their respective antigens but not with uninfected
mosquito cells.
Inhibition of MAb binding with serum samples from WNV-
infected chickens. The six WNV-reactive MAbs were charac-
terized in blocking ELISAs performed with a pooled suspen-
sion of serum samples collected 14 days postinfection from
several WNV-infected chickens (anti-WNV serum samples).
WNV coating antigen and MAbs were tested at multiple dilu-
tions, at dilutions that resulted in the greatest inhibition of
MAb-binding used for all subsequent ELISAs. Optimal anti-
body dilutions ranged from 1:4 to 1:80 for MAbs produced as
hybridoma culture supernatants and 1:2,000 to 1:16,000 for
MAbs that were mouse ascitic fluids (Table 2). For all MAbs,
the optimal dilution of WNV antigen was 1:100. Under these
conditions, we were able to achieve 47% inhibition of MAb
binding in all assays. The most promising results were obtained
with MAbs 3.1112G, 2B2, and 6B6C-1, yielding 85.3%, 79.3%,
and 71.8% inhibition, respectively. Assays that utilized these
MAbs were also effective in detecting antibodies in anti-WNV
chicken serum samples collected at 19, 28, and 31 days postin-
fection. The SLEV-specific MAb 6B5A-2 was optimized in
blocking assays with SLEV antigen and a pooled suspension of
serum samples from multiple avian species infected with SLEV
(anti-SLEV serum samples; data not shown). Optimal antigen
and MAb dilutions were 1:100 and 1:1,000, respectively.
Inhibition of MAb binding with serum samples from WNV-
infected crows. Next, the diagnostic efficacy of each blocking
assay was characterized for its ability to detect WNV antibod-
ies in serum samples from corvids. Eight fish crows were ex-
perimentally infected with WNV (six of which had been vac-
cinated against this virus prior to infection), and serum
samples were collected at 14 days postinfection. All serum
samples were positive in blocking assays performed with MAbs
2B2, 3.1112G, and 3.67G, with mean inhibition values of
87.1%, 69.4%, and 60.5%, respectively (Table 3). As explained
below, an inhibition value of 30% was chosen as the diag-
nostic criterion to indicate the presence of flavivirus-specific
antibodies. Six serum samples tested positive with WNV MAb
3.91D; the mean inhibition value in this assay was 40.9%. The
MAbs to SLEV and Murray Valley encephalitis virus were less
effective, with five, three, and two specimens being positive
with MAbs 6B6C-1, 3H6, and 6B5A-2, respectively. No major
difference in MAb inhibition was observed when comparing
TABLE 2. Inhibition of WNV-reactive MAbs by blocking ELISA
with sera from chickens infected with WNVa
MAb OptimalMAb dilution
% Inhibition of MAb binding at time between
infection and serum collection (days)b:
14 19 28 31
2B2 1:40 79.3 1.8 69.0 3.7 49.7 5.4 61.0 5.7
3.1112G 1:2,000 85.3 0.7 87.8 0.5 71.6 2.0 82.3 0.3
3.67G 1:80 58.6 4.7 67.7 0.3 49.2 4.3 51.8 2.2
3.91D 1:40 47.2 6.6 NT NT NT
6B6C-1 1:16,000 71.8 2.6 84.4 1.9 72.4 2.6 79.3 2.1
3H6 1:4 60.3 1.8 NT NT NT
a MAbs were tested in triplicate. All sera were diluted 10-fold.
b Values are means  standard deviations. NT, not tested.
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serum samples from vaccinated and nonvaccinated birds (Ta-
ble 3).
No noticeable pattern was observed when the percent inhi-
bition values of each MAb were compared except for MAbs
3.67G and 3.91D. For each individual serum sample, the per-
cent inhibition value reported with MAb 3.67G was approxi-
mately 20% higher than the corresponding value for MAb
3.91D. It is noteworthy to mention that, of all the antibodies
used in these studies, only MAbs 3.67G and 3.91D were raised
against the same virus strain and protein (Tables 1 and 3). To
ascertain the sensitivity of the blocking assays, all anti-WNV
crow serum samples were serially diluted twofold, starting at a
dilution of 1:10, and tested against MAbs 3.67G, 2B2, and
3.1112G. The last two antibodies worked particularly well, with
all eight serum samples significantly inhibiting the binding of
these MAbs at dilutions of 1:320 (Table 4). Correlation of
the ELISA endpoint titers to the PRNT90 endpoint titers re-
vealed that the former technique showed superior sensitivity in
detecting antibodies in these particular serum samples.
Analysis of serum samples from WNV- and SLEV-infected
birds of multiple species. The ability of blocking assays to
detect flavivirus antibodies in serum samples from many bird
species and to distinguish between WNV and SLEV infections
was determined. ELISAs were conducted with serum samples
from 13 WNV-infected laboratory birds that represented eight
species and seven families and seven field-captured SLEV-
infected birds (five species, five families). Control serum sam-
ples from 12 birds (nine species, eight families) with no previ-
ous exposure to either virus were also included. Overall, serum
samples were collected from 32 individual birds that belonged
to 16 species and 10 families. ELISAs were performed with the
WNV MAbs 2B2, 3.1112G, and 3.67G and the SLEV MAbs
6B6C-1 and 6B5A-2.
Analysis of control serum samples obtained from uninfected
birds revealed that the mean nonspecific inhibition value was
6.7% for MAb 2B2, 7.0% for MAb 3.1112G, 3.5% for MAb
3.67G, 5.2% for MAb 6B6C-1, and 4.1% for MAb 6B5A-2
(Table 5). The highest nonspecific inhibition value was 24.3%,
and therefore the diagnostic criterion selected was 30%.
Percent inhibition values were calculated by comparing the
optical density of the test serum to that of the control serum
from uninfected chickens. In some instances, when percent
inhibitions could be calculated with a control serum from an
uninfected bird of the same species, similar inhibition values
were obtained (data not shown).
The most effective assays for the detection of WNV serum
antibodies were those performed with MAbs 3.1112G and 2B2
(Table 5). All 13 anti-WNV serum samples were positive with
these antibodies. The efficiencies of these assays were similar,
with a mean inhibition value of 66.5% for MAb 3.1112G and
59.6% for MAb 2B2. There was no apparent correlation be-
tween the MAb inhibition value and PRNT titer, in that a high
inhibition value did not necessarily correspond to a high PRNT
titer. For MAb 3.1112G, the mean inhibition value for anti-
WNV serum samples with PRNT titers of 160 and 160 was
65.1% and 68.2%, respectively. For MAb 2B2, the mean inhi-
bition value for anti-WNV serum samples with PRNT titers of
160 and 160 was 56.9% and 62.8%, respectively. Analysis
of the seven anti-SLEV serum samples revealed that five were
positive with MAb 2B2 but none were positive with MAb
3.1112G. Assays performed with MAb 6B6C-1 were also ef-
fective when tested against anti-WNV serum samples. The
mean inhibition value for this MAb was 64.6%, and all serum
samples except one were positive for viral antibodies. MAb
3.67G worked reasonably well, with viral antibodies detected in
most (10 of 13) anti-WNV serum samples.
The most efficient assay for the detection of SLEV serum
antibodies utilized MAb 6B6C-1. All anti-SLEV serum sam-
ples inhibited the binding of this MAb by64%, and the mean
inhibition value was 79.8% (Table 5). MAb 6B5A-2 also
readily detected flavivirus antibodies in anti-SLEV serum sam-
ples; all specimens except one were positive. The serum sample
that failed to demonstrate significant MAb inhibition was from
a rock dove with a low PRNT titer. However, low PRNT titers
TABLE 3. Inhibition of MAbs by blocking ELISA with sera from crows infected with WNV
Sample
serum
no.
Crow
vaccinated
% Inhibition of MAba
2B2 3.1112G 3.67G 3.91D 6B6C-1 6B5A-2 3H6
1 Yes 98.4  0.4 67.2  6.8 74.4  4.5 52.4 49.9 74.1 50.0
2 Yes 96.4  0.8 62.3  5.5 89.8  2.0 75.0 15.0 11.5 0
3 No 89.3  4.2 71.3  4.7 52.8  4.0 30.2 35.0 26.6 14.3
4 Yes 69.2  8.5 70.0  5.6 44.8  5.2 28.4 38.5 0 28.7
5 Yes 93.0  1.1 65.5  6.2 77.5  5.2 48.8 76.5 66.1 69.2
6 Yes 87.3  2.9 85.1  3.2 47.8  6.3 19.6 28.0 16.1 19.3
7 Yes 69.1  7.5 56.0  5.2 40.1  10.8 39.1 56.0 0 40.5
8 No 93.9  3.2 78.1  5.7 57.1  8.0 33.8 0 12.8 0
Mean 87.1 69.4 60.5 40.9 37.4 25.9 27.8
a Values are means  standard deviations. Inhibition values of 30% are considered significant. MAbs 2B2, 3.1112G, and 3.67G were tested in triplicate. All other
MAbs were tested in duplicate. All sera were diluted 10-fold.
TABLE 4. Determination of serum antibody titers in anti-WNV
crow sera by blocking ELISA and PRNT
Anti-WNV
crow serum
sample no.
PRNT90
titer
ELISA titer
2B2 3.1112G 3.67G
1 320 10,240 640 1,280
2 320 5,120 640 10,240
3 160 320 1,280 80
4 320 640 640 80
5 160 5,120 640 2,560
6 40 640 640 40
7 80 320 640 160
8 160 1,280 2,560 1,280
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did not necessarily correlate to low percent inhibition values.
For example, there was 93.9% inhibition with MAb 6B5A-2
when testing an anti-SLEV serum sample from a European
starling with a PRNT90 titer of 20. There was 87.7% inhibition
with MAb 6B5A-2 when testing anti-SLEV serum from an-
other rock dove with a PRNT90 titer of 320. Interestingly, the
single sample that was negative was also one of the two anti-
SLEV samples that were negative with MAb 2B2. One of two
anti-WNV serum samples from a Japanese quail was positive
with MAb 6B5A-2.
To further assess the sensitivity of the assays, three randomly
selected serum samples were tested at multiple dilutions
against MAbs 2B2, 3.1112G, 6B5A-2, and 6B6C-1. We tested
one anti-WNV serum sample from a Japanese quail and two
anti-SLEV serum samples from a rock dove and graylag goose.
Serum samples were serially twofold diluted, with a starting
dilution of 1:10 and a final dilution of 1:5,120. Best results were
obtained with MAb 6B6C-1, with significant inhibition of MAb
binding observed with all three serum samples at a dilution of
1:5,120 (data not shown).
DISCUSSION
We developed epitope-blocking ELISAs that reliably detect
WNV serum antibodies in numerous North American avian
species. The most efficient assays utilized MAbs 2B2 and
3.1112G; antibodies were detected in all WNV-infected birds
when these MAbs were used. However, most serum samples
from birds infected with the closely related SLEV were also
positive with MAb 2B2. In contrast, all anti-SLEV serum sam-
ples failed to block the binding of MAb 3.1112G, suggesting
that this assay can be exploited in North American surveillance
studies to differentiate between WNV and SLEV infections.
Indeed, this assay is routinely used to monitor sentinel chick-
ens in northwestern Australia, as it differentiates between Kun-
jin virus infections and those caused by other flaviviruses found
in this region, namely Murray Valley encephalitis virus and
KOKV (9). Moreover, this assay has been exploited to screen
2,500 serum samples from numerous avian species captured
throughout the United States and shown to specifically identify
infections with WNV (R. H. Evans, M. Jozan, F. Stebbins, C.
TABLE 5. Inhibition of MAbs by blocking ELISA with anti-WNV, anti-SLEV, and normal sera from multiple avian speciesa
Serum type and avian species WNVPRNT90 titer
SLEV
PRNT90 titer
% Inhibition of MAb:
2B2 3.1112G 3.67G 6B6C-1 6B5A-2
Anti-WNV
American robin 40 84.8 86.4 45.8 24.4 0
Blue jay 320 56.1 70.0 33.4 58.1 0
Canada goose-1 320 59.7 65.0 44.1 63.2 22.0
Canada goose-2 320 65.1 67.4 40.1 70.3 2.2
Japanese quail-1 80 51.0 60.8 18.1 65.1 40.7
Japanese quail-2 40 51.6 38.5 35.0 64.1 12.3
Killdeer-1 320 85.1 76.8 36.8 77.0 0
Killdeer-2 160 44.5 57.4 35.1 68.1 28.4
Monk parakeet 80 43.3 56.5 27.9 68.4 0
Mourning dove 40 41.6 88.6 2.7 62.4 0
Ring-necked pheasant-1 80 46.5 62.0 35.7 77.6 0
Ring-necked pheasant-2 160 66.0 72.6 40.5 80.5 0
Ring-necked pheasant-3 40 79.4 62.9 44.8 60.5 2.2
Mean 59.6 66.5 33.8 64.6 8.3
Anti-SLEV
Domestic turkey 640 49.3 17.7 16.8 91.4 94.1
European starling-1 40 20.2 6.3 7.2 75.4 47.4
European starling-2 20 45.4 0.7 7.7 64.9 93.9
Graylag goose 160 44.5 13.1 15.2 91.9 83.3
House sparrow 160 57.0 7.5 18.0 93.2 85.0
Rock dove-1 320 86.0 0 15.4 76.8 87.7
Rock dove-2 40 12.2 0 9.3 65.1 11.8
Mean 44.9 6.5 12.8 79.8 71.9
Normal
American crow-1 9.6 15.7 13.8 0 15.0
American crow-2 5.5 11.1 5.6 0 7.0
American crow-3 4.2 5.0 0 0 0
American robin-1 0 8.2 0.6 0 14.6
American robin-2 0 9.5 0 0 5.3
Graylag goose 10.1 5.0 5.5 21.9 0.6
House finch 15.2 0 0 4.1 0
House sparrow 3.6 10.8 2.2 12.7 7.2
Japanese quail 11.6 5.6 3.2 0 0
Monk parakeet 0 0 1.6 0 0
Mourning dove 4.5 2.0 5.7 0 0
Northern bobwhite 15.8 5.8 3.7 24.3 0
Mean 6.7 7.0 3.5 5.2 4.1
a Titers of 10 are not shown. Inhibition values of 30% are considered significant. All sera were diluted 10-fold.
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Fogarty, K. Abeyta, R. A. Hall, and B. Tangredi, Abstr. 70th
Annu. Conf. Mosquito Vector Control Assoc. California,
2002).
ELISAs that utilized MAb 3.67G were specific for WNV
antibodies, albeit several anti-WNV serum samples failed to
test positive, while MAb 6B5A-2 generally detected antibodies
in SLEV-infected but not WNV-infected birds. The most effi-
cient assay for the detection of serum antibodies to SLEV
utilized MAb 6B6C-1. Serum antibodies were detected in all
SLEV-infected birds and most WNV-infected birds with this
assay. The blocking assays reported here, unlike PRNTs or
hemagglutination inhibition assays, provide a rapid and inex-
pensive serologic technique suitable for large-scale screening
of serum specimens.
MAbs 2B2 and 6B5A-2 did not recognize SLEV and WNV
antigens, respectively, by direct ELISA. However, blocking
assays performed with MAb 2B2 detected antibodies in most
anti-SLEV serum samples, and the binding of MAb 6B5A-2
was blocked by several anti-WNV serum samples. Presumably,
the inability of these MAbs to react with their epitopes in the
presence of serum antibodies against the other virus is a con-
sequence of steric hindrance. That is, antibodies common to
both viruses are binding to nearby epitopes, thereby blocking
the binding of the MAb. Flavivirus cross-reactive and type-
specific MAbs have been shown to compete with one another
in competitive binding assays (22).
Assays performed with MAbs 2B2 and 3.67G were more
efficient in detecting antibodies in fish crows than in the other
WNV-infected bird species tested. In contrast, antibodies were
detected in only five of eight fish crows in the assay that utilized
MAb 6B6C-1, whereas almost all other birds infected with
either WNV or SLEV tested positive. These findings may
reflect the different inoculation methods and/or virus doses
used in these experiments. Fish crows were subcutaneously
inoculated, but all other anti-WNV serum samples were from
birds that had been experimentally inoculated via infected
mosquitoes, and all anti-SLEV serum samples were obtained
from wild birds. However, it is unlikely that the assay per-
formed with MAb 3.1112G simply discriminated between ex-
perimental and naturally acquired infections rather than WNV
and SLEV infections. Earlier studies have shown that this
assay discriminates between WNV and SLEV antibodies in
naturally infected chickens (12).
Recently, antibody capture ELISAs were designed for the
routine diagnosis of WNV infections in humans, and these
assays were shown to be highly sensitive (19, 26). Similarly, the
blocking ELISAs reported here displayed high levels of sensi-
tivity. No obvious correlation between ELISA percent inhibi-
tion values and PRNT titers was observed, although this was
not unexpected, as these tests do not necessarily detect the
same antibody types. That is, blocking assays can detect serum
antibodies that have no neutralizing ability. Comparison of
antibody titers determined by blocking ELISA and PRNT90
revealed that the former technique was superior in sensitivity
when examining serum samples collected at 14 days postinfec-
tion. However, it is important to note that neutralizing anti-
bodies have a greater longevity than nonneutralizing antibod-
ies (4). Therefore, blocking assays may not necessarily display
superior sensitivity over PRNTs when used to test serum sam-
ples from field-captured birds. Titration experiments indicated
that the assay performed with MAb 6B6C-1 was the most
sensitive in detecting serum antibodies in birds that had been
experimentally infected by mosquitoes or naturally infected. It
is possible that this assay displayed greater sensitivity because
MAb 6B6C-1 is horseradish peroxidase labeled, unlike the
other antibodies used in these experiments.
The blocking assays reported here are currently being used
to monitor potential WNV activity in migratory and resident
avian populations in Mexico. We are screening bird serum
samples in ELISAs with MAb 3.1112G to specifically identify
WNV infection and MAb 6B6C-1 to detect flavivirus cross-
reactive antibodies. Additional studies in our laboratories will
determine whether these assays can also detect antibodies to
other flaviviruses found in the Americas, such as ILHV and
BSQV. Recent studies have shown that our ELISAs can be
exploited to detect WNV infections in various species of do-
mestic mammals (unpublished data).
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